Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.650
-0.020 (-0.43%)
At close: Sep 17, 2025, 4:00 PM EDT
4.830
+0.180 (3.87%)
Pre-market: Sep 18, 2025, 8:39 AM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $609.62 million as of September 18, 2025. Its market cap has increased by 21.62% in one year.
Market Cap
609.62M
Enterprise Value
627.61M
1-Year Change
21.62%
Ranking
Category
Stock Price
$4.65
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $609.62M, a decrease of -62.54%. That is a compound annual growth rate of -28.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 612.24M | 64.33% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |